Page last updated: 2024-09-03

way 100135 and sincalide

way 100135 has been researched along with sincalide in 1 studies

Compound Research Comparison

Studies
(way 100135)
Trials
(way 100135)
Recent Studies (post-2010)
(way 100135)
Studies
(sincalide)
Trials
(sincalide)
Recent Studies (post-2010) (sincalide)
1430344,01572533

Protein Interaction Comparison

ProteinTaxonomyway 100135 (IC50)sincalide (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.0006
Cholecystokinin receptor type AHomo sapiens (human)0.0006
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001
Gastrin/cholecystokinin type B receptorMus musculus (house mouse)0.0008
Cholecystokinin receptor type ACavia porcellus (domestic guinea pig)0.0004

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bickerdike, MJ; Fletcher, A; Marsden, CA1

Other Studies

1 other study(ies) available for way 100135 and sincalide

ArticleYear
Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
    Neuropharmacology, 1995, Volume: 34, Issue:7

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Behavior, Animal; Cholecystokinin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Peptide Fragments; Piperazines; Pyridines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Sincalide; Time Factors

1995